Name: Cryopreservation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells at the Optimal Stage (Video) | JoVE Journal
Uploaded: 2023-11-03T13:20:00.000+00:00
Duration: 7 min 3 s
Description: Learn a cryopreservation protocol for human stem cell-derived retinal pigment epithelial cells at the optimal exponential phase. This method improves survival rates and supports retinal replacement therapies.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This work was funded by the National Natural Science Foundation of China (81970816) to Mei Jiang; the National Natural Science Foundation of China (82201223) to Xinyue Zhu; and the Science and Technology Innovation Action Plan of the Shanghai Science and Technology Commission (2014090067000) to Haiyun Liu.

1. Cell dissociation
<ol>
	<li>Maintain RPE cells as previously described17,22. 
	NOTE: All cells are grown at 37 &#176;C in a 5% CO2 atmosphere throughout the duration of the protocols.</li>
	<li>Prepare the required amount of PBS and culture medium in a 37 &#176; C water bath and place the cell dissociation reagent at room temperature.</li>
	<li>Discard the culture solution and wash the plates twice with 1 mL of preheated PBS per well.</li>
	<li>Add 1 mL of the cell dissociation reagent to the 6-well plates and digest the cells at 37 &#176;C for 15 min. After incubation, observe the cells that shrink and shine at the edges under a microscope to confirm the termination of digestion. 
	NOTE: Trypsin-based dissociation is not recommended as it gives low cell viability.</li>
	<li>Pipette up and down gently 10x with a 1 mL pipette to dissociate the cells, and dilute the cell suspension with preheated culture medium (without Y-27632) at a ratio of 1:10. Then, centrifuge the cells at room temperature for 3 min at 250 &#215; g.</li>
	<li>Quickly pour out the supernatant after centrifugation, gently resuspend the cell pellet in 2 mL of the culture medium, and resuspend the cells 10-15x with a pipette.</li>
	<li>Filter the cell suspension with a 40 &#181;m cell strainer to obtain a single-cell suspension and calculate the number of cells. 
	&#8203;NOTE: A single-cell suspension is essential for accurate cell counting and uniform cell seeding density after thawing.</li>
</ol>
2. Determination of the optimal cell stage for cryopreservation
NOTE: Because the cell state varies between differentiation methods and cell lines, the exponential phase of RPE cells cultured at different laboratories should be determined before freezing.
<ol>
	<li>Thaw one vial of basement membrane matrix solution on ice at 4 &#176;C overnight. Dilute the matrix into 12 mL of cold DMEM/F-12 and mix well. Add one coverslip per well, and coat each well of a 24-well plate with 0.25 mL of the diluted solution. Incubate the plate&#160;for 1 h at room temperature or overnight at 4 &#176;C before use and aspirate the coating solution just before plating the cells. 
	NOTE: Instructions for aliquot volume are lot-specific based on the protein concentration and are found in the product specification sheet.</li>
	<li>Seed the RPE single cells from step 1.7 on the basement membrane matrix-coated coverslips at a density of 105/cm2 in 1 mL of culture medium. Refresh the culture medium every 2-3 days.</li>
	<li>At indicated time points (1, 3, 5, 7, and 11 days after passage), incubate RPE cells with 10 &#956;M EdU in the medium for 24 h. Fix, permeabilize, and stain the cells with the reaction cocktail as described in the manual to detect incorporated EdU.</li>
	<li>Capture images from five random fields under a fluorescence microscope and calculate the percentage of EdU-positive cells. Plot the corresponding EdU-positive proportion-time curves to generate a growth curve. Then, determine the freezing window or the exponential phase for each cell line according to the growth curve. 
	&#8203;NOTE: Reestablished hexagonal cell morphology indicates that cells exit the exponential phase.</li>
</ol>
3. Cryopreservation
<ol>
	<li>Following steps 1.1 to 1.7, except that the digestion time decreases to 5 min, centrifuge the cell suspension at room temperature for 3 min at 250 &#215; g.</li>
	<li>Discard the supernatant by quickly pouring after centrifugation and gently resuspend the cell pellet in the cryopreservation medium to a density of 2 &#215; 106 cells/mL and transfer 1 mL of the cell suspension to 1.2 mL cryogenic vials.</li>
	<li>Immediately place the cryogenic vials in a freezing container, freeze at &#8722;80 &#176;C overnight to achieve a cooling rate of &#8722;1 &#176;C/min, and then transfer the vials to liquid nitrogen for long-term storage.</li>
</ol>
4. Thawing
<ol>
	<li>Warm the culture medium in a 37 &#176;C water bath and prefill 10 mL of prewarmed culture medium into a 15 mL tube.</li>
	<li>Rapidly thaw the cryogenic vials directly taken from the liquid nitrogen storage using an automated thawing system.</li>
	<li>Drip 0.5-1 mL of preheated culture medium into the cryogenic vial to ensure that the frozen cells gradually adapt to the new environment. Then, transfer 1.5-2 mL of the cell suspension to 10 mL of the culture medium in a 15 mL tube and centrifuge the cells at 250 &#215; g for 3 min at room temperature.</li>
	<li>Discard the supernatant by quickly pouring after centrifugation, resuspend the pellet in 2 mL of preheated culture medium, and count the number of cells using a hemocytometer to determine recovery and survival rates using standard trypan blue exclusion (0.4% trypan blue stain).</li>
	<li>Culture the cells on basement membrane matrix-coated surfaces at a density of 105 viable cells/cm2 in a culture medium supplemented with Y-27632 (final concentration: 10 &#181;M). Remove Y-27632 after 24 h.</li>
	<li>To determine the attachment rate, dissociate the cells again and count the number of cells 24 h after thawing.</li>
</ol>
5. Validation of the optimal freezing phase
<ol>
	<li>To validate the optimal freezing phase determined in step 2.4, thaw RPE cells frozen at different time points and culture for 28 days. Harvest the cells for qPCR and immunostaining analysis to evaluate the expression of RPE markers as previously described17.</li>
</ol>

Advancing Cryostorage of Human Stem Cell-Derived Retinal Pigment Epithelial Cells

<ol><li>Lakkaraju, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+cell+biology+of+the+retinal+pigment+epithelium%5BTitle%5D)+AND+%22Progress+in+Retinal+and+Eye+Research%22%5BJournal%5D)">The cell biology of the retinal pigment epithelium.</a> Progress in Retinal and Eye Research. 78, 100846(2020).</li>
<li>Mcbain, V. A., Townend, J., Lois, N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Progression+of+retinal+pigment+epithelial+atrophy+in+stargardt+disease%5BTitle%5D)+AND+%22American+Journal+of+Ophthamology%22%5BJournal%5D)">Progression of retinal pigment epithelial atrophy in stargardt disease.</a> American Journal of Ophthamology. 154 (1), 146-154 (2012).</li>
<li>George, S. M., Lu, F., Rao, M., Leach, L. L., Gross, J. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+retinal+pigment+epithelium%3A+Development%2C+injury+responses%2C+and+regenerative+potential+in+mammalian+and+non-mammalian+systems%5BTitle%5D)+AND+%22Progress+in+Retinal+and+Eye+Research%22%5BJournal%5D)">The retinal pigment epithelium: Development, injury responses, and regenerative potential in mammalian and non-mammalian systems.</a> Progress in Retinal and Eye Research. 85, 100969(2021).</li>
<li>Rizzolo, L. J., Nasonkin, I. O., Adelman, R. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Retinal+cell+transplantation%2C+biomaterials%2C+and+in+vitro+models+for+developing+next-generation+therapies+of+age-related+macular+degeneration%5BTitle%5D)+AND+%22Stem+Cells+Translational+Medicine%22%5BJournal%5D)">Retinal cell transplantation, biomaterials, and in vitro models for developing next-generation therapies of age-related macular degeneration.</a> Stem Cells Translational Medicine. 11 (3), 269-281 (2022).</li>
<li>Bertolotti, E., Neri, A., Camparini, M., Macaluso, C., Marigo, V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Stem+cells+as+source+for+retinal+pigment+epithelium+transplantation%5BTitle%5D)+AND+%22Progress+in+Retinal+and+Eye+Research%22%5BJournal%5D)">Stem cells as source for retinal pigment epithelium transplantation.</a> Progress in Retinal and Eye Research. 42, 130-144 (2014).</li>
<li>Da Cruz,, L,, et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Phase+1+clinical+study+of+an+embryonic+stem+cell-derived+retinal+pigment+epithelium+patch+in+age-related+macular+degeneration%5BTitle%5D)+AND+%22Nature+Biotechnology%22%5BJournal%5D)">Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration.</a> Nature Biotechnology. 36 (4), 328-337 (2018).</li>
<li>Mehat, M. S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Transplantation+of+human+embryonic+stem+cell-derived+retinal+pigment+epithelial+cells+in+macular+degeneration%5BTitle%5D)+AND+%22Ophthalmology%22%5BJournal%5D)">Transplantation of human embryonic stem cell-derived retinal pigment epithelial cells in macular degeneration.</a> Ophthalmology. 125 (11), 1765-1775 (2018).</li>
<li>Buchholz, D. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Rapid+and+efficient+directed+differentiation+of+human+pluripotent+stem+cells+into+retinal+pigmented+epithelium%5BTitle%5D)+AND+%22Stem+Cells+Translational+Medicine%22%5BJournal%5D)">Rapid and efficient directed differentiation of human pluripotent stem cells into retinal pigmented epithelium.</a> Stem Cells Translational Medicine. 2 (5), 384-393 (2013).</li>
<li>Li, Q. -Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Functional+assessment+of+cryopreserved+clinical+grade+hESC-RPE+cells+as+a+qualified+cell+source+for+stem+cell+therapy+of+retinal+degenerative+diseases%5BTitle%5D)+AND+%22Experimental+Eye+Research%22%5BJournal%5D)">Functional assessment of cryopreserved clinical grade hESC-RPE cells as a qualified cell source for stem cell therapy of retinal degenerative diseases.</a> Experimental Eye Research. 202, 108305(2021).</li>
<li>Francois, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cryopreserved+mesenchymal+stromal+cells+display+impaired+immunosuppressive+properties+as+a+result+of+heat-shock+response+and+impaired+interferon-gamma+licensing%5BTitle%5D)+AND+%22Cytotherapy%22%5BJournal%5D)">Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-gamma licensing.</a> Cytotherapy. 14 (2), 147-152 (2012).</li>
<li>Moll, G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Do+cryopreserved+mesenchymal+stromal+cells+display+impaired+immunomodulatory+and+therapeutic+properties%5BTitle%5D)+AND+%22Stem+Cells%22%5BJournal%5D)">Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties.</a> Stem Cells. 32 (9), 2430-2442 (2014).</li>
<li>Ekpo, M. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Incorporating+cryopreservation+evaluations+into+the+design+of+cell-based+drug+delivery+systems%3A+an+opinion+paper%5BTitle%5D)+AND+%22Frontiers+in+Immunology%22%5BJournal%5D)">Incorporating cryopreservation evaluations into the design of cell-based drug delivery systems: an opinion paper.</a> Frontiers in Immunology. 13, 967731(2022).</li>
<li>Bailey, T. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Protective+effects+of+osmolytes+in+cryopreserving+adherent+neuroblastoma+%28Neuro-2a%29+cells%5BTitle%5D)+AND+%22Cryobiology%22%5BJournal%5D)">Protective effects of osmolytes in cryopreserving adherent neuroblastoma (Neuro-2a) cells.</a> Cryobiology. 71 (3), 472-480 (2015).</li>
<li>Okumura, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Feasibility+of+a+cryopreservation+of+cultured+human+corneal+endothelial+cells%5BTitle%5D)+AND+%22PLoS+One%22%5BJournal%5D)">Feasibility of a cryopreservation of cultured human corneal endothelial cells.</a> PLoS One. 14 (6), e0218431(2019).</li>
<li>Pennington, B. O., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Xeno-free+cryopreservation+of+adherent+retinal+pigmented+epithelium+yields+viable+and+functional+cells+in+vitro+and+in+vivo%5BTitle%5D)+AND+%22Scientific+Reports%22%5BJournal%5D)">Xeno-free cryopreservation of adherent retinal pigmented epithelium yields viable and functional cells in vitro and in vivo.</a> Scientific Reports. 11 (1), 6286(2021).</li>
<li>Woods, E. J., Thirumala, S., Badhe-Buchanan, S. S., Clarke, D., Mathew, A. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Off+the+shelf+cellular+therapeutics%3A+Factors+to+consider+during+cryopreservation+and+storage+of+human+cells+for+clinical+use%5BTitle%5D)+AND+%22Cytotherapy%22%5BJournal%5D)">Off the shelf cellular therapeutics: Factors to consider during cryopreservation and storage of human cells for clinical use.</a> Cytotherapy. 18 (6), 697-711 (2016).</li>
<li>Zhang, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Determining+the+optimal+stage+for+cryopreservation+of+human+embryonic+stem+cell-derived+retinal+pigment+epithelial+cells%5BTitle%5D)+AND+%22Stem+Cell+Research+%26+Therapy%22%5BJournal%5D)">Determining the optimal stage for cryopreservation of human embryonic stem cell-derived retinal pigment epithelial cells.</a> Stem Cell Research & Therapy. 13 (1), 454(2022).</li>
<li>Leach, L. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Induced+pluripotent+stem+cell-derived+retinal+pigmented+epithelium%3A+a+comparative+study+between+cell+lines+and+differentiation+Methods%5BTitle%5D)+AND+%22Journal+of+Ocular+Pharmacology+and+Therapeutics%22%5BJournal%5D)">Induced pluripotent stem cell-derived retinal pigmented epithelium: a comparative study between cell lines and differentiation Methods.</a> Journal of Ocular Pharmacology and Therapeutics. 32 (5), 317-330 (2016).</li>
<li>Reichman, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Generation+of+storable+retinal+organoids+and+retinal+pigmented+epithelium+from+adherent+human+iPS+cells+in+Xeno-free+and+feeder-free+conditions%5BTitle%5D)+AND+%22Stem+Cells%22%5BJournal%5D)">Generation of storable retinal organoids and retinal pigmented epithelium from adherent human iPS cells in Xeno-free and feeder-free conditions.</a> Stem Cells. 35 (5), 1176-1188 (2017).</li>
<li>Brandl, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((In-depth+characterisation+of+retinal+pigment+epithelium+%28RPE%29+cells+derived+from+human+induced+pluripotent+stem+cells+%28hiPSC%29%5BTitle%5D)+AND+%22Neuromolecular+Medicine%22%5BJournal%5D)">In-depth characterisation of retinal pigment epithelium (RPE) cells derived from human induced pluripotent stem cells (hiPSC).</a> Neuromolecular Medicine. 16 (3), 551-564 (2014).</li>
<li>Hongisto, H., Ilmarinen, T., Vattulainen, M., Mikhailova, A., Skottman, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Xeno-+and+feeder-free+differentiation+of+human+pluripotent+stem+cells+to+two+distinct+ocular+epithelial+cell+types+using+simple+modifications+of+one+method%5BTitle%5D)+AND+%22Stem+Cell+Research+%26+Therapy%22%5BJournal%5D)">Xeno- and feeder-free differentiation of human pluripotent stem cells to two distinct ocular epithelial cell types using simple modifications of one method.</a> Stem Cell Research & Therapy. 8 (1), 291(2017).</li>
<li>Foltz, L. P., Clegg, D. O. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Rapid%2C+directed+differentiation+of+retinal+pigment+epithelial+cells+from+human+embryonic+or+induced+pluripotent+stem+cells%5BTitle%5D)+AND+%22Journal+of+Visualized+Experiments%3A+JoVE%22%5BJournal%5D)">Rapid, directed differentiation of retinal pigment epithelial cells from human embryonic or induced pluripotent stem cells.</a> Journal of Visualized Experiments: JoVE. (128), 10.3791/56274(2017).</li>
<li>Marcantonini, G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Natural+cryoprotective+and+cytoprotective+agents+in+cryopreservation%3A+a+focus+on+melatonin%5BTitle%5D)+AND+%22Molecules%22%5BJournal%5D)">Natural cryoprotective and cytoprotective agents in cryopreservation: a focus on melatonin.</a> Molecules. 27 (10), 3254(2022).</li>
</ol>

The authors have no conflicts of interest to disclose.

In the present study, a successful freeze-thaw protocol for hESC-derived RPE cells for research and clinical needs is described. Unlike the immortalized RPE cell line, ARPE-19, RPE cells with proper characteristic epithelial phenotype and function, like stem cell derived-RPE cells, are more sensitive to cryopreservation. Less than 32% of the cells remained at 24 h post thaw if not properly preserved17. Cryopreservation timing is a critical parameter. An established view for immortalized cell cryop...

The retinal pigment epithelium (RPE) is a pigmented monolayer of cells required for maintaining the proper function of the retina1. RPE dysfunction and death are closely associated with many retinal degenerative diseases, including age-related macular degeneration, retinitis pigmentosa, and Stargardt disease2,3. RPE replacement therapy is one of the most promising treatment regimens for these diseases4,5,6,7. A stable supply of donor RPE cells is vital for cell therapy. Human embryonic stem cell (hESC)-derived RPE cells are an ideal cell source for cell therapy because they mimic the function of primary RPE cells and can produce a theoretically unlimited supply8. However, the differentiation process is laborious and the shelf-life of the obtained RPE cells is relatively short because of subsequent epithelial-mesenchymal transition (EMT). Therefore, the cryopreservation of hESC-derived RPE cells is an indispensable step required for long-term storage and on-demand distribution9.
Cryopreservation-induced cellular damage can inadvertently compromise therapeutic efficacy10,11. Therefore, recent studies on cryopreservation have proposed that optimal cryogenic storage conditions should be determined when designing cell therapies12. Successful cryopreservation guarantees efficient cell recovery, high viability, and cell function restoration after the freeze-thaw cycle. However, previous studies on the cryopreservation of the adherent monolayers of mammalian cells have reported highly variable (35%-95%) survival rates after thawing13,14,15. Many factors considerably affect the outcomes of cryopreservation, particularly during the freezing stage16,17. Recent research showed that RPE cells frozen at different time points exhibited varied recovery after thawing17. To the best of our knowledge, studies on the determination of the optimal freezing time window for stem cell-derived RPE cells are lacking. In different studies, the cells were frozen at various stages: some cells were frozen shortly after passaging or before confluency or pigmentation8,15,18, whereas others were frozen at other time points9,19,20,21. Furthermore, there is no clear evidence of whether the phase or stage of RPE cells used for cryopreservation affects RPE function after thawing. In our previous study, we demonstrated for the first time that the exponential phase of cell growth (P2D5) is the best stage for the cryopreservation of hESC-derived RPE cells in terms of cell viability and the recovery of cellular properties and functions17.
The method established here aims to cryopreserve hESC-derived RPE at an optimal stage to achieve the best preservation in terms of cell viability and function after thawing. Using the 5-ethynyl-2&#39;-deoxyuridine (EdU) labeling assay to detect the exponential phase of DNA synthesis before cryopreservation, thawed RPE cells exhibited &#62;80% viability and attachment rate, RPE-specific gene expression, polarized cell morphology, pigment epithelium-derived factor secretion, appropriate transepithelial resistance, and phagocytic ability8,17,22. Although this protocol focuses&#160;on hESC-derived RPE cells and not all therapeutic cells are equally cryopreserved, the strategy of freezing in the exponential phase may be applied to many other therapeutic cells.

<table><tbody><tr><td>40 &amp;mu;m Cell strainer</td><td>Corning</td><td>431750</td><td></td></tr><tr><td>Click-iT EdU Cell Proliferation Kit for Imaging, Alexa Fluor 488 Dye</td><td>Thermo Fisher Scientific</td><td>C10337</td><td></td></tr><tr><td>Cryo freezing container</td><td>Nalgene</td><td>5100-0001</td><td></td></tr><tr><td>CryoStor CS10</td><td>Biolife Solutions</td><td>07930</td><td>cryopreservation medium #1</td></tr><tr><td>DPBS, no calcium, no magnesium</td><td>Thermo Fisher Scientific</td><td>14190144</td><td></td></tr><tr><td>Genxin</td><td>Selcell</td><td>YB050050</td><td>cryopreservation medium #2</td></tr><tr><td>Human embryonic stem cells</td><td>provided by Wicell, USA</td><td>H9 cell line</td><td></td></tr><tr><td>Matrigel, hESC-Qualified Matrix</td><td>Corning</td><td>354277</td><td>basement membrane matrix</td></tr><tr><td>ThawSTAR CFT2 Automated Cell Thawing System</td><td>BioLife Solutions</td><td>AST-601</td><td></td></tr><tr><td>Trypan Blue solution 0.4%</td><td>Sigma</td><td>T8154</td><td></td></tr><tr><td>TryPLE Select</td><td>Thermo Fisher Scientific</td><td>12563029</td><td>cell dissociation reagent</td></tr><tr><td>XVIVO-10 medium</td><td>Lonza</td><td>BEBP04-743Q</td><td>RPE culture medium</td></tr><tr><td>Y-27632</td><td>Selleck</td><td>S1049</td><td></td></tr></tbody></table>

cryopreservation of human embryonic stem cell-derived retinal pigment epithelial cells at the optimal stage

Cryopreservation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells at the Optimal Stage

Retinal pigment epithelial&#160;(RPE) cells derived from human embryonic stem cells (hESCs) are superior cell sources for cell replacement therapy in individuals with retinal degenerative diseases; however, studies on the stable and secure banking of these therapeutic cells are scarce. Highly variable cell viability and functional recovery of&#160;RPE cells after cryopreservation are the most commonly encountered issues. In the present protocol, we aimed to achieve the best cell recovery rate after thawing by selecting the optimal cell phase for freezing based on the original experimental conditions. Cells were frozen in the exponential phase determined by using the 5-ethynyl-2&#8242;-deoxyuridine labeling assay, which improved cell viability and recovery rate after thawing. Stable and functional cells were obtained shortly after thawing, independent of a long differentiation process. The methods described here allow the simple, efficient, and inexpensive preservation and thawing of hESC-derived RPE cells. Although this protocol focuses on RPE cells, this freezing strategy may be applied to many other types of differentiated cells.

Here, hESC-derived RPE cells at P1D35 were passaged and seeded at a density of 105/cm2. Within a week of seeding, the characteristic hexagonal morphology and pigmentation were lost during the lag phase (approximately 2 days). RPE cells gradually readopted the hexagonal morphology in the exponential phase (approximately 5 days, Figure 1A) and entered the deceleration phase (approximately 6 days) with a more polygonal morphology. If cell culturing was continued for anothe...

This study provides a detailed protocol for the efficient cryopreservation of human stem cell-derived retinal pigment epithelial cells.

Retinal pigment epithelial&#160;(RPE) cells derived from human embryonic stem cells (hESCs) are superior cell sources for cell replacement therapy in ...

cryopreservation-human-embryonic-stem-cell-derived-retinal-pigment

Research

JoVE Journal

Medicine

Stem cell-derived retinal pigment epithelium  (RPE) cells may be used for multiple applications including cell-based therapies for retinal degeneration, disease modeling, and drug studies. Here we present a simple protocol for reproducibly deriving RPE from stem cells.

Efficient Derivation of Retinal Pigment Epithelium Cells from Stem Cells

Here we present a community accepted protocol in multimedia format for subretinally injecting a bolus of RPE cells in rats and mice. This approach can be used for determining rescue potentials, safety profiles, and survival capacities of grafted RPE cells upon implantation in animal models of retinal degeneration.

Performing Subretinal Injections in Rodents to Deliver Retinal Pigment Epithelium Cells in Suspension

This protocol describes how to produce retinal pigment epithelial cells (RPE) from pluripotent stem cells. The method uses a combination of growth factors and small molecules to direct the differentiation of stem cells into immature RPE in fourteen days and mature, functional RPE after three months.

Rapid, Directed Differentiation of Retinal Pigment Epithelial Cells from Human Embryonic or Induced Pluripotent Stem Cells

Retinal pigment epithelial cells could serve as a cell-replacement therapy for the advanced form of dry age-related macular degeneration. This protocol describes the generation of a large-eyed model of geographic atrophy and the subretinal transplantation of human embryonic stem cell-derived retinal pigment epithelial cells into this model of disease.

Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy

The production of specialized retinal cells from pluripotent stem cells is a turning point in the development of stem cell-based therapy for retinal diseases. The present paper describes a simple method for an efficient generation of retinal organoids and retinal pigmented epithelium for basic, translational, and clinical research.

Defined Xeno-free and Feeder-free Culture Conditions for the Generation of Human iPSC-derived Retinal Cell Models

We describe a method to engineer a retinal tissue composed of retinal pigment epithelial cells derived from human pluripotent stem cells cultured on top of human amniotic membranes and its preparation for grafting in animal models.

Engineering Transplantation-suitable Retinal Pigment Epithelium Tissue Derived from Human Embryonic Stem Cells

This protocol introduces a simple two-step method for differentiating corneal limbal epithelial stem cells from human pluripotent stem cells under xeno- and feeder cell-free culture conditions. The cell culture methods presented here enable cost-efficient, large-scale production of clinical quality cells applicable to corneal cell therapy use.

Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells

Presented here is a surgical technique for transplanting human pluripotent stem cell (hPSC)-derived retinal tissue into the subretinal space of a large animal model.

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

We describe a detailed protocol for the preparation of post-cryopreserved hESC-derived photoreceptor progenitor cells and the sub-retinal delivery of these cells in rd10 mice.

Sub-Retinal Delivery of Human Embryonic Stem Cell Derived Photoreceptor Progenitors in rd10 Mice

The method described isolation and characterization of human Dental Pulp Stem Cells (hDPSCs) by using either enzymatic dissociation of pulp (DPSC-ED) or direct outgrowth of stem cells from pulp tissue explants (DPSC-OG). Then followed by in vitro comparative differentiation of both types of hDPSCs into odontoblasts.

Isolation, Characterization and Comparative Differentiation of Human Dental Pulp Stem Cells Derived from Permanent Teeth by Using Two Different Methods

Learn a cryopreservation protocol for human stem cell-derived retinal pigment epithelial cells at the optimal exponential phase. This method improves survival rates and supports retinal replacement therapies.

Cryopreservation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells at the Optimal Stage

Explore More Videos